Systemic changes in numerous metabolic processes must occur during pregnancy for the female’s body to support the growing fetus. One such change is an increase in maternal insulin production. An increase in maternal insulin production facilitates glucose transport to the fetus, but this can often result in increased insulin resistance in maternal cells. In some cases, this may manifest itself as gestational diabetes. We show that alterations of glucose metabolism due to pregnancy is sustained to some degree in females that do not participate in lactation. This idea is supported through epidemiological findings suggesting that this effect increases a woman’s risk of developing type II diabetes later in life relative to women who do breastfeed [
5,
37]. In contrast to pregnancy, there is a decrease in insulin secretion during lactation returning to pre-pregnancy levels that is associated with a decline in β-cell proliferation and improved insulin sensitivity [
13].
Importantly, our finding of higher liver protein levels of PPARδ in PL rats may help explain how glucose metabolism may be increased due to a lactation period. PPARδ plays a significant role in the regulation of glucose metabolism and insulin sensitivity [
29] and Sanderson and collaborators demonstrated its importance in the liver. Specifically, knockout models of PPARδ had lower expression of genes relating to glucose metabolism and higher plasma glucose in a fasted state compared to wild type mice [
38]. These studies and our data, in which fasted serum glucose was decreased and liver PPARδ protein expression was higher in PL rats, suggest that the resulting modulation of PPARδ expression persists after lactation and is at least one mechanism that may confer a phenotype that protects against type II diabetes. In addition, we report that mitochondrial respiratory function was enhanced in PL rats when using complex I substrates, as indicated by a higher RCR. Considering that complex I respiration plays a large role in the utilization of glucose, via high NADH:FADH
2 production, our findings provides a mechanistic outcome for the enhanced ability of cells in PL rats to metabolize glucose. Interestingly, measurements of enzymatic activity of the electron transport system show that both PP and PL rats had higher complex I activity. Our findings of increased liver complex I mitochondrial function in PL animals may be better explained by the increased protein expression of PGC-1α and PPARδ. While PPARδ knockout models have demonstrated that PPARδ is involved in the expression of genes relating to oxidative metabolism, PGC-1α is a well-known regulator of mitochondrial biogenesis and coactivator of genes involved in oxidative phosphorylation [
28]. Thus, increased expression of these proteins likely results in the improved mitochondrial function observed. PL rats also expressed lower liver complex II activity compared to both PP and NR, and lower respiration when using complex II substrates. This down regulation of complex II respiration further limits use of FADH
2 to fuel OXPHOS, and as a result, likely down regulates fat metabolism via beta oxidation, an effect that further supports the use of glucose as the primary fuel to support ATP production in PL rats. During pregnancy, the mother’s body experiences increasing visceral adiposity [
12]. During lactation however, a shift in lipoprotein lipase and triacylglyceride levels facilitate the mobilization of fats to the mammary gland to be used for milk synthesis [
14]. In contrast to PPARδ’s role in liver, PPARδ in WAT is involved in catabolic effects through oxidation of fatty acids [
30]. Our data show that PPARδ protein expression is higher in WAT of PL rats compared to NR and PP rats. Our findings of increased PPARδ protein expression in two functionally different tissues also demonstrate that a systemic signaling event is a likely candidate for driving these changes.